Clinical Trial Update: Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating fecal filtrate as a treatment for recurrent Clostridioides difficile infection is ongoing or not yet reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• fecal filtrate

Snippet

Sponsor: University of Pecs | Conditions: Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection | Phase 3 | Status: UNKNOWN